Long Term Care Devices Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Long Term Care Devices Market Trends and Insights

Rapidly Ageing Population & Chronic-Disease Burden

The global population aged 60+ will reach 2.1 billion by 2050, double 2020 levels, while Japan already spends 40% more per capita on fall-detection wearables than the OECD average. Chronic diseases drive 90% of U.S. healthcare costs, urging payers to reimburse devices that curb readmissions.^{[1]CDC, “Chronic Diseases in America,” Centers for Disease Control and Prevention, cdc.gov} Physician shortages projected at 124,000 in the United States intensify reliance on technology-enabled coordination.^{[2]AMA, “The Complexities of Physician Supply and Demand,” American Medical Association, ama-assn.org}

Rising Home-Healthcare / Aging-in-Place Models

Medicare’s ACCESS Model rewards tech-enabled home care, and remote physiologic monitoring claims rose tenfold from 2019-2022. Scotland is investing GBP 300 million to outfit 50,000 homes with telehealth infrastructure^{[3]CMS, “Guide: Home Health Value-Based Purchasing Model,” Centers for Medicare & Medicaid Services, cms.gov}while 77% of U.S. adults over 50 prefer aging in place.

Breakthroughs in Portable & Connected Devices

The FDA cleared 21 novel RPM devices in 2024, including Abbott’s FreeStyle Libre 3 and Medtronic’s Simplera CGM, both streaming glucose data to smartphones. Wearable BioButton patches track multiple vitals for 90 days, replacing Holter monitors in long term care settings. Predetermined change-control plans now allow in-field AI updates without new 510(k) filings.

AI-Based Predictive Maintenance Lowering TCO

GE Healthcare’s OnWatch forecasts component failure 30 days in advance and cut unplanned downtime by 22% in German hospital pilots. Philips’ IntelliVue monitors offer similar analytics bundled within subscription contracts. These tools eliminate emergency service calls worth USD 15,000 per nursing home annually.

High Upfront Cost of Advanced Devices

Cellular blood-pressure monitors cost USD 300-500 versus USD 50 for basic units, pushing payback to 18-24 months for 100-bed facilities. Integration, middleware, and IT add 20-30% to ownership costs, and rural India lacks broadband at 88% of primary centers 

Lithium & Rare-Earth Supply Constraints

China controls 60% of rare-earth refining and 80% of lithium-ion cell production, while lithium carbonate prices peaked at USD 80,000/ton in 2022. U.S. domestic lithium refining only began in 2024 at 30,000 tons capacity.

Segment Analysis

By Product Type: Therapeutic Devices Anchor Revenue, Mobility Aids Accelerate

Therapeutic Devices held 44.14% share in 2025, buoyed by infusion pumps and dialysis systems that boost the long term care devices market size for capital equipment. Mobility Assist Devices will rise at 9.24% CAGR as falls remain the top cause of fatal injury among older adults. 

Smart wheelchairs like Permobil’s M5 Corpus integrate tilt and elevation via smartphone control, illustrating the shift toward sensor-rich mobility aids. Diagnostic devices benefit from home-based testing, yet reimbursement gaps slow uptake in some regions.

Note: Segment shares of all individual segments available upon report purchase

By Indication: Chronic-Disease Management Dominates, Rehabilitation Gathers Pace

Chronic-Disease Management commanded 53.67% of demand in 2025, fueled by 537 million adults living with diabetes. Rehabilitation and Mobility Impairment will register a 9.54% CAGR through 2031, supported by AI-guided exoskeletons like Ekso NR that shorten therapy time by 30%. Palliative care remains smaller yet grows as intrathecal pumps such as Medtronic’s SynchroMed II allow hospice patients to remain at home longer.

By Technology: AI-Enabled Platforms Disrupt Legacy Installations

Traditional Non-connected Devices still represent 59.62% of volume, but AI-enabled Smart-Analytics Devices will expand at 11.44% CAGR, driven by FDA guidance that eases algorithm updates. Cybersecurity requirements now mandate software bills of materials for networked devices 

Note: Segment shares of all individual segments available upon report purchase

By Device Portability: Wearables Redefine Continuous Monitoring

Stationary Installed Equipment retains high-value share, yet Wearable Body-worn Devices will log the quickest CAGR at 11.64%, led by Abbott’s FreeStyle Libre 3 and BioIntelliSense’s BioButton. Mobile Portable Devices remain critical for oxygen therapy and mobile imaging.

By End User: Home Healthcare Leads, Assisted Living Gains Momentum

Home Healthcare secured 48.74% share in 2025 thanks to reimbursement that rewards in-home monitoring. Assisted Living Facilities will grow at 10.53% CAGR, adopting radar-based fall detection from providers like Vayyar Care. Hospices and nursing homes prioritize devices with clear ROI, particularly RPM platforms that cut emergency transfers.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America accounted for 36.13% of 2025 revenue, propelled by USD 4.1 trillion in U.S. healthcare spending and FDA pathways for home-use devices. Canada pilots rural RPM programs, while Mexico’s growing middle class boosts chronic-care device demand. 

Asia-Pacific is expected to deliver a 9.76% CAGR through 2031, underpinned by China’s 280 million citizens over 60 and Japan’s subsidies for monitoring devices in 3,000 facilities. India’s Ayushman Bharat plans 150,000 wellness centers with telemedicine kits by 2027. 

Europe benefits from universal coverage and stricter MDR evidence requirements that favor incumbents. The UK’s carbon-weighted tenders and France’s expanded RPM reimbursement broaden demand, while GCC investments and Brazil’s telehealth pilots lift emerging-market adoption.